SMAD2 and hepatocellular carcinoma: Taking together, our research explored that Smad2/3/4 complex could undergo LLPS and binds to TAT gene promotor site to upregulate TAT expression, which can active caspase-9 to induce hepatoma cell apoptosis (Fig. 8).